Association of PON-1 polymorphism with susceptibility to and severity of ischemic stroke in the Chinese population.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY Personalized medicine Pub Date : 2022-05-01 Epub Date: 2022-01-31 DOI:10.2217/pme-2021-0133
Jianmin Huang, Yanfang Yun, Haiyan Chen, Guixin Yang, Yongming Jiang, Yaoxin Pan, Shengshan Yuan, Jianjun Huang, Li Su, Yingning Wu, Dong Lu, Anding Xu, Xuebin Li
{"title":"Association of <i>PON-1</i> polymorphism with susceptibility to and severity of ischemic stroke in the Chinese population.","authors":"Jianmin Huang,&nbsp;Yanfang Yun,&nbsp;Haiyan Chen,&nbsp;Guixin Yang,&nbsp;Yongming Jiang,&nbsp;Yaoxin Pan,&nbsp;Shengshan Yuan,&nbsp;Jianjun Huang,&nbsp;Li Su,&nbsp;Yingning Wu,&nbsp;Dong Lu,&nbsp;Anding Xu,&nbsp;Xuebin Li","doi":"10.2217/pme-2021-0133","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> The authors aimed to investigate whether polymorphisms of <i>PON-1</i> were associated with the susceptibility to and severity of ischemic stroke (IS). <b>Methods:</b> In this study, 302 IS patients and 303 healthy controls were enrolled. Polymorphisms rs854560 and rs854572 of <i>PON-1</i> were detected using SNaPshot single-nucleotide polymorphism typing technology. <b>Results:</b> The rs854572 polymorphism of the <i>PON-1</i> gene showed a significant correlation with IS, and its GG genotype reduced the risk of IS (recessive model, p = 0.001). The GG genotype was also associated with mild stroke (p = 0.032). No association was observed between rs854560 and IS. <b>Conclusion:</b><i>PON-1</i> rs854572 polymorphism was related to the risk of IS and could be a biomarker to access the severity of IS.</p>","PeriodicalId":19753,"journal":{"name":"Personalized medicine","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pme-2021-0133","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3

Abstract

Aim: The authors aimed to investigate whether polymorphisms of PON-1 were associated with the susceptibility to and severity of ischemic stroke (IS). Methods: In this study, 302 IS patients and 303 healthy controls were enrolled. Polymorphisms rs854560 and rs854572 of PON-1 were detected using SNaPshot single-nucleotide polymorphism typing technology. Results: The rs854572 polymorphism of the PON-1 gene showed a significant correlation with IS, and its GG genotype reduced the risk of IS (recessive model, p = 0.001). The GG genotype was also associated with mild stroke (p = 0.032). No association was observed between rs854560 and IS. Conclusion:PON-1 rs854572 polymorphism was related to the risk of IS and could be a biomarker to access the severity of IS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PON-1多态性与中国人群缺血性卒中易感性和严重程度的关系
目的:探讨PON-1基因多态性是否与缺血性脑卒中(IS)易感性和严重程度相关。方法:本研究纳入302例IS患者和303例健康对照。采用SNaPshot单核苷酸多态性分型技术检测PON-1基因rs854560和rs854572多态性。结果:PON-1基因rs854572多态性与IS有显著相关性,其GG基因型降低IS发病风险(隐性模型,p = 0.001)。GG基因型也与轻度脑卒中相关(p = 0.032)。rs854560与IS无关联。结论:PON-1 rs854572多态性与IS发病风险相关,可作为判断IS病情严重程度的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Personalized medicine
Personalized medicine 医学-药学
CiteScore
3.30
自引率
4.30%
发文量
49
审稿时长
6-12 weeks
期刊介绍: Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
期刊最新文献
Improving resource allocation in the precision medicine Era: a simulation-based approach using R Challenges and opportunities in building a health economic framework for personalized medicine in oncology. Developing and validating noninvasive prenatal testing for de novo autosomal dominant monogenic diseases in Vietnam. Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1